|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 235/06 | (2006.01) |
| C07C 233/41 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07D 207/273 | (2006.01) |
| (11) | Number of the document | 3655395 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18785785.9 |
| Date of filing the European patent application | 2018-07-19 | |
| (97) | Date of publication of the European application | 2020-05-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-01 |
| (46) | Date of publication of the claims translation | 2022-03-10 |
| (86) | Number | PCT/US2018/042797 |
| Date | 2018-07-19 |
| (87) | Number | WO 2019/018592 |
| Date | 2019-01-24 |
| (30) | Number | Date | Country code |
| 201762534908 P | 2017-07-20 | US |
| (72) |
AYTAR, Burcu Selin , US
BOROVIKA, Alina , US
CHAN, Collin , US
DEERBERG, Joerg , US
DOMAGALSKI, Nathan R. , US
EASTGATE, Martin D. , US
FAN, Yu , US
FENSTER, Michael David Bengt , US
FOREST, Robert V. , US
GONZALEZ-BOBES, Francisco , US
GREEN, Rebecca A. , US
HICKEY, Matthew R. , US
KOPP, Nathaniel David , US
LA CRUZ, Thomas E. , US
LAUSER, Kathleen , US
LEE, Hong Geun , KR
LEAHY, David K. , US
LUO, Helen Y. , US
RAZLER, Thomas M. , US
SAVAGE, Scott A. , US
SFOUGGATAKIS, Chris , US
SOUMEILLANT, Maxime C.D. , US
ZARETSKY, Serge , US
ZHENG, Bin , US
ZHU, Ye , SG
|
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | N-((1R,2S,SR)-5-(tret-butilamino)-2-((S)-3-(7-tret-butilpirazolo[1,5-a][1,3,5]triazin-4-ilamino)-2-oksopirolidin-1-il)cikloheksil)acetamido gamybos būdas |
| PROCESS FOR THE PREPARATION OF N-((1R,2S,SR)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE |
| Payment date | Validity (years) | Amount | |
| 2023-07-03 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-07-19 |